Novo Nordisk
NVO
703 hedge funds and large institutions have $9.54B invested in Novo Nordisk in 2020 Q4 according to their latest regulatory filings, with 97 funds opening new positions, 230 increasing their positions, 226 reducing their positions, and 44 closing their positions.
120% more first-time investments, than exits
New positions opened: 97 | Existing positions closed: 44
24% more call options, than puts
Call options by funds: $68M | Put options by funds: $54.6M
7% more funds holding
Funds holding: 660 → 703 (+43)
2% more repeat investments, than reductions
Existing positions increased: 230 | Existing positions reduced: 226
0.32% less ownership
Funds ownership: 15.38% → 15.06% (-0.32%)
2% less capital invested
Capital invested by funds: $9.68B → $9.54B (-$146M)
42% less funds holding in top 10
Funds holding in top 10: 12 → 7 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$18.3M |
| 2 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$18.2M |
| 3 |
Morgan Stanley
New York
|
+$14.3M |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$13.8M |
| 5 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$11.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$88.5M |
| 2 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$48.6M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$40.1M |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$31.4M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$25.6M |
NVO Hedge Fund Activity: Q4 2020 in Review
703 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q4 2020, worth a combined $9.54B — down 1.5% from $9.68B a quarter earlier.
Buyers outnumbered sellers: 97 funds opened new NVO positions and 44 closed out — a net gain of 53 holders — while 230 added to existing stakes and 226 trimmed.
The largest buyer was Old Mission Capital, opening a new position worth an estimated $18.3M. The largest seller was Renaissance Technologies, cutting an estimated $88.5M.
- 703 institutional investors held Novo Nordisk (NVO) as of Q4 2020, up from 660 in Q3 2020.
- Funds reported $9.54B of Novo Nordisk stock for Q4 2020, down 1.5% quarter-over-quarter.
- 97 funds opened new Novo Nordisk positions in Q4 2020 and 44 closed out, a net change of +53 holders.
- The largest Novo Nordisk buyer in Q4 2020 was Old Mission Capital, an estimated $18.3M added.
- The largest Novo Nordisk seller in Q4 2020 was Renaissance Technologies, an estimated $88.5M sold.
Based on aggregated 13F filings for Q4 2020.